BB Biotech AG (XSWX:BION) Beneish M-Score: 0.00 (As of Jun. 26, 2026)


XSWX:BION BB Biotech AG XSWX:BION
33 GF Score
Price CHF47.80
! 3 Warning Signs
View Full Analysis

What is BB Biotech AG Beneish M-Score?

BB Biotech AG XSWX:BION +2.14% 33 Beneish M-Score is 0.00 as of Jun. 26, 2026. GuruFocus rates XSWX:BION with a GF Score™ of 33/100. The stock has 3 warning signs investors should review. Among 831 Biotechnology companies, BB Biotech AG ranks worse than 120336.82% on this metric.

Note: Financial institutions were excluded from the sample in Beneish paper when calculating Beneish M-Score. Thus, the prediction might not fit banks and insurance companies.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

The historical rank and industry rank for BB Biotech AG's Beneish M-Score or its related term are showing as below:

During the past 13 years, the highest Beneish M-Score of BB Biotech AG was 3.18. The lowest was -2.44. And the median was -1.49.

XSWX:BION
33GF Score
BB Biotech AG XSWX:BION
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BB Biotech AG Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of BB Biotech AG for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * +0.528 * +0.404 * +0.892 * +0.115 *
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * +4.679 * -0.327 *
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was CHF0.0 Mil.
Revenue was -17.039 + 474.845 + 454.34 + -93.71 = CHF818.4 Mil.
Gross Profit was -17.039 + 474.845 + 454.34 + -93.71 = CHF818.4 Mil.
Total Current Assets was CHF0.0 Mil.
Total Assets was CHF2,641.2 Mil.
Property, Plant and Equipment(Net PPE) was CHF0.0 Mil.
Depreciation, Depletion and Amortization(DDA) was CHF0.0 Mil.
Selling, General, & Admin. Expense(SGA) was CHF19.7 Mil.
Total Current Liabilities was CHF0.0 Mil.
Long-Term Debt & Capital Lease Obligation was CHF0.0 Mil.
Net Income was -21.377 + 471.685 + 447.622 + -100.24 = CHF797.7 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = CHF0.0 Mil.
Cash Flow from Operations was 373.707 + 16.14 + 63.81 + -59.96 = CHF393.7 Mil.
 Total Receivables was CHF0.0 Mil.
Revenue was -238.99 + 61.366 + -149.685 + -79.333 = CHF-406.6 Mil.
Gross Profit was -238.99 + 61.366 + -149.685 + -79.333 = CHF-406.6 Mil.
Total Current Assets was CHF0.0 Mil.
Total Assets was CHF1,948.9 Mil.
Property, Plant and Equipment(Net PPE) was CHF0.0 Mil.
Depreciation, Depletion and Amortization(DDA) was CHF0.0 Mil.
Selling, General, & Admin. Expense(SGA) was CHF17.8 Mil.
Total Current Liabilities was CHF0.0 Mil.
Long-Term Debt & Capital Lease Obligation was CHF0.0 Mil.

1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(0 / 818.436) / (0 / -406.642)
=0 /
=

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(-406.642 / -406.642) / (818.436 / 818.436)
= / 1
=

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (0 + 0) / 2641.182) / (1 - (0 + 0) / 1948.87)
=1 / 1
=

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=818.436 / -406.642
=

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0 / (0 + 0)) / (0 / (0 + 0))
= /
=

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(19.711 / 818.436) / (17.811 / -406.642)
=0.024084 /
=

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0 + 0) / 2641.182) / ((0 + 0) / 1948.87)
=0 / 0
=

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(797.69 - 0 - 393.697) / 2641.182
=0.152959

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of 0.00 mean?
BB Biotech AG (XSWX:BION) has a Beneish M-Score of 0.00 as of Jun. 26, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on BB Biotech AG and its competitors. According to the industry distribution chart, BB Biotech AG ranks #999999 out of 831 companies in the Biotechnology industry.
Is BB Biotech AG's Beneish M-Score too high?
BB Biotech AG's current Beneish M-Score is 0.00. Based on the distribution chart, BB Biotech AG ranks #999999 out of 831 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, BB Biotech AG has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does BB Biotech AG's Beneish M-Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, BB Biotech AG ranks #999999 out of 831 companies for Beneish M-Score. This places BB Biotech AG in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Biotechnology company?
A good Beneish M-Score depends on the Biotechnology industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on BB Biotech AG and its competitors. BB Biotech AG's current Beneish M-Score is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BB Biotech AG stock overvalued right now?
BB Biotech AG (XSWX:BION) has a current Beneish M-Score of 0.00. The current Beneish M-Score is 0.00. BB Biotech AG's overall GF Score™ is 33/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For BB Biotech AG (XSWX:BION), the current Beneish M-Score is 0.00 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BB Biotech AG Business Description

Address Schwertstrasse 6, Schaffhausen, CHE, CH-8200
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market, and is one of the investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system. Geographically company operates in the USA, Netherlands, Singapore, Great Britain, Canada, Switzerland, Curacao, and British Virgin Island.
33GF Score

Get the complete analysis for XSWX:BION

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF47.80
Price